Sponsor Check › Issuer
Corporation · organized in DELAWARE · formed 2009 · SCOTTSDALE, AZ · SEC CIK 1471972
Data last updated: Oct 23, 2026, 5:45 PM ET · Latest filing by this issuer: Mar 12, 2014 · Courts (RECAP) last checked: not yet · SEC enforcement last checked: not yet
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
Not yet searched.
Sources to be searched: CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
No public statement by this issuer has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known only from an approved profile claim or the Form ADV of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this issuer yet.
0 of 5 offerings report sales commissions; 0 report finder's fees; 1 reports proceeds to related persons totalling $100,000. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Mar 12, 2014 D File 021-213402 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 24, 2013 D File 021-190756 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 19, 2011 D File 021-164711 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 12, 2010 D File 021-150466 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 12, 2010 D/A File 021-134308 | $0 | $0 | $100,000 (est.) James Clough & Jacqueline Jensen are of counsel with Quinlivan & Wexler, LLP & will receive payment for legal fees from the proceeds of the offering. Alan Roga will receive $50,000 from the proceeds of the offering in connection with repayment of a loan. | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
0 recorded documents and 0 ownership records matched to Stat Health Services Inc. in the sources searched.
Not found in sources searched as of Oct 23, 2026, 8:59 PM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Florida DOR NAL roll (Hillsborough 39) roll year 2026 — loaded Oct 23, 2026, 8:54 PM ET; Florida DOR NAL roll (Dade 23) roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Harris County Appraisal District real_acct.txt roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET. Not yet searched for this issuer (queued): NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.
Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Hillsborough County FL (recorded documents from Oct 14, 2026 forward; ownership from FL DOR roll 2026); Cook County IL (assessor ownership and deed/sale records, looked up per issuer when its page is viewed); Harris County TX and Dallas County TX (assessor ownership rolls only, 2026 roll; no deed, mortgage or sale records); Miami-Dade County FL (ownership from FL DOR roll only; Clerk recorded documents not yet searched). Recorder indexes for TX, AZ, IL and WA counties, mortgages and liens outside NYC and FL, lis pendens and foreclosure notices everywhere, Miami-Dade County FL recorded documents, Maricopa County AZ, King County WA, Salt Lake County UT, and all other counties are not yet searched. Last refresh: Oct 23, 2026, 11:30 PM ET; last subject check: Oct 23, 2026, 11:49 PM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.
Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.
| File no. | Original Form D | Latest filing | Amendments | Offered (latest) | Sold (latest) | Industry (latest) |
|---|---|---|---|---|---|---|
| 021-213402 | Mar 12, 2014 EDGAR ↗ | Mar 12, 2014 D EDGAR ↗ | 0 | $3,500,000 | $3,500,000 | Other |
| 021-190756 | Jan 24, 2013 EDGAR ↗ | Jan 24, 2013 D EDGAR ↗ | 0 | $3,130,000 | $3,000,000 | Other Health Care |
| 021-164711 | Aug 19, 2011 EDGAR ↗ | Aug 19, 2011 D EDGAR ↗ | 0 | $2,250,000 | $550,000 | Other Health Care |
| 021-150466 | Nov 12, 2010 EDGAR ↗ | Nov 12, 2010 D EDGAR ↗ | 0 | $3,000,000 | $50,000 | Other Health Care |
| 021-134308 | Sep 10, 2009 EDGAR ↗ | May 12, 2010 D/A EDGAR ↗ | 1 latest May 12, 2010 | $3,000,000 | $1,750,000 | Other Health Care |
Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.
| Filing | Form D filed Mar 12, 2014 SEC file no. 021-213402 · accession 0001471972-14-000001 |
|---|---|
| Raise progress | $3,500,000 sold of $3,500,000 offered (100%) · $0 remaining · first sale Feb 27, 2014 |
| Filing timing | Date of first sale: Feb 27, 2014 · Form D filed: Mar 12, 2014 (13 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 4,622 days (12.7 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 1 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed 2009 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | John Barravecchia, Chief Financial Officer (Mar 11, 2014) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $5,000–$50,000. Offering size: $3,500,000. Typical range: $500,000–$7,000,000. Investors: 1. Typical range: 2–14. "Similar" = industry reported as "Other", Rule 506(b). Based on 18,678 Form D filings 2021–2026 in the same industry and exemption (Other, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 6,590, offering size 16,855, investors 16,531. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Jan 24, 2013 SEC file no. 021-190756 · accession 0001471972-13-000001 |
|---|---|
| Raise progress | $3,000,000 sold of $3,130,000 offered (96%) · $130,000 remaining · first sale Jan 9, 2013 |
| Filing timing | Date of first sale: Jan 9, 2013 · Form D filed: Jan 24, 2013 (15 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 5,036 days (13.8 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 1 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed 2009 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Alan C. Roga, M.D., Chief Executive Officer (Jan 24, 2013) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $3,130,000. Typical range: $829,831–$9,999,998. Investors: 1. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Aug 19, 2011 SEC file no. 021-164711 · accession 0001471972-11-000003 |
|---|---|
| Raise progress | $550,000 sold of $2,250,000 offered (24%) · $1,700,000 remaining · first sale Aug 3, 2011 |
| Filing timing | Date of first sale: Aug 3, 2011 · Form D filed: Aug 19, 2011 (16 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 5,561 days (15.2 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 2 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed 2009 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Alan C. Roga, M.D., Chief Executive Officer (Aug 18, 2011) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $2,250,000. Typical range: $829,831–$9,999,998. Investors: 2. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Nov 12, 2010 SEC file no. 021-150466 · accession 0001471972-10-000005 |
|---|---|
| Raise progress | $50,000 sold of $3,000,000 offered (2%) · $2,950,000 remaining · first sale Nov 1, 2010 Issuer's note: Class A Common Stock |
| Filing timing | Date of first sale: Nov 1, 2010 · Form D filed: Nov 12, 2010 (11 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 5,836 days (16.0 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 1 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $50,000 |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed 2009 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Alan C. Roga, Chief Executive Officer (Nov 12, 2010) |
| Market context | Minimum investment: $50,000. Typical range for similar offerings: $10,000–$54,310. Offering size: $3,000,000. Typical range: $829,831–$9,999,998. Investors: 1. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D/A (amendment) filed May 12, 2010 · amends 0001471972-09-000004 ↗ SEC file no. 021-134308 · accession 0001471972-10-000003 · filing 7 of 7 in this offering |
|---|---|
| Raise progress | $1,750,000 sold of $3,000,000 offered (58%) · $1,250,000 remaining Issuer's note: Class A Common Stock |
| Filing timing | Date of first sale: Yet to occur · Original Form D filed: Sep 10, 2009 · This amendment (Form D/A) filed: May 12, 2010 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. This filing is an amendment dated May 12, 2010. Most recent amendment for this offering in our index: this filing, May 12, 2010. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 22 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $50,000 |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed 2009 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $100,000 (est.) Issuer's note: James Clough & Jacqueline Jensen are of counsel with Quinlivan & Wexler, LLP & will receive payment for legal fees from the proceeds of the offering. Alan Roga will receive $50,000 from the proceeds of the offering in connection with repayment of a loan. |
| Signed by | Alan Roga, Chief Executive Officer (May 12, 2010) |
| Changes vs previous filing |
Compared with the D filed Apr 1, 2010 (EDGAR ↗). The issuer's form cites 0001471972-09-000004 as the filing it amends; the comparison here is with the filing immediately before this one in the same offering. Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $50,000. Typical range for similar offerings: $10,000–$54,310. Offering size: $3,000,000. Typical range: $829,831–$9,999,998. Investors: 22. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Apr 1, 2010 SEC file no. 021-134308 · accession 0001471972-10-000002 · filing 6 of 7 in this offering |
|---|---|
| Raise progress | $17 sold of $17 offered (100%) · $0 remaining · first sale Mar 1, 2010 Issuer's note: Warrant to purchase 17,604 Shares of Class A Common Stock. Issuer has not received, and may never receive, the proceeds from this offering. |
| Filing timing | Date of first sale: Mar 1, 2010 · Form D filed: Apr 1, 2010 (31 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 6,081 days (16.7 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: May 12, 2010 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 1 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Entity details | Organized in DELAWARE · formed 2009 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Alan Roga, Chief Executive Officer (Apr 1, 2010) |
| Changes vs previous filing |
Compared with the D filed Feb 8, 2010 (EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $17. Typical range: $829,831–$9,999,998. Investors: 1. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Feb 8, 2010 SEC file no. 021-134308 · accession 0001471972-10-000001 · filing 5 of 7 in this offering |
|---|---|
| Raise progress | $996,000 sold of $996,000 offered (100%) · $0 remaining · first sale Feb 2, 2010 Issuer's note: Options to purchase Class A and Class B Common Stock and the underlying shares of Class A and Class B Common Stock issuable upon exercise thereof. 2009 Equity Incentive Plan B. |
| Filing timing | Date of first sale: Feb 2, 2010 · Form D filed: Feb 8, 2010 (6 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 6,108 days (16.7 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: May 12, 2010 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 2 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Option, warrant or other right to acquire; Security to be acquired upon exercise |
| Entity details | Organized in DELAWARE · formed 2009 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jacqueline M. Jensen, Secretary (Feb 5, 2010) |
| Changes vs previous filing |
Compared with the D filed Nov 20, 2009 (EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $996,000. Typical range: $829,831–$9,999,998. Investors: 2. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Nov 20, 2009 SEC file no. 021-134308 · accession 0001471972-09-000004 · filing 4 of 7 in this offering |
|---|---|
| Raise progress | $0 sold of $3,000,000 offered (0%) · $3,000,000 remaining Issuer's note: Class A Common Stock |
| Filing timing | Date of first sale: Yet to occur · Form D filed: Nov 20, 2009 Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: May 12, 2010 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 0 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $50,000 |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed 2009 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $100,000 (est.) Issuer's note: James Clough & Jacqueline Jensen are of counsel with Quinlivan & Wexler, LLP & will receive payment for legal fees from the proceeds of the offering. Alan Roga will receive $50,000 from the proceeds of the offering in connection with repayment of a loan. |
| Signed by | Alan Roga, Acting Chief Executive Officer (Nov 20, 2009) |
| Changes vs previous filing |
Compared with the D filed Sep 23, 2009 (EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $50,000. Typical range for similar offerings: $10,000–$54,310. Offering size: $3,000,000. Typical range: $829,831–$9,999,998. Investors: 0. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Sep 23, 2009 SEC file no. 021-134308 · accession 0001471972-09-000003 · filing 3 of 7 in this offering |
|---|---|
| Raise progress | $102,000 sold of $200,000 offered (51%) · $98,000 remaining · first sale Sep 14, 2009 Issuer's note: Convertible Promissory Notes and shares of Class A Common Stock issuable upon conversion thereof. |
| Filing timing | Date of first sale: Sep 14, 2009 · Form D filed: Sep 23, 2009 (9 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 6,249 days (17.1 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: May 12, 2010 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 7 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity; Debt |
| Entity details | Organized in DELAWARE · formed 2009 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.) Issuer's note: James Clough and Jacqueline M. Jenson, who are persons required to be named in Item No. 3 above, are Of Counsel with Quinlivan Wexler LLP, a law firm that will receive payment for legal fees from the proceeds of the subject Convertible Note offering. |
| Signed by | Alan Roga, Chief Executive Officer (Sep 23, 2009) |
| Changes vs previous filing |
Compared with the D filed Sep 10, 2009 (EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $200,000. Typical range: $829,831–$9,999,998. Investors: 7. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Sep 10, 2009 SEC file no. 021-134308 · accession 0001471972-09-000002 · filing 2 of 7 in this offering |
|---|---|
| Raise progress | $12,500 sold of $12,500 offered (100%) · $0 remaining · first sale Aug 28, 2009 Issuer's note: Class A Common Stock |
| Filing timing | Date of first sale: Aug 28, 2009 · Form D filed: Sep 10, 2009 (13 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 6,266 days (17.2 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: May 12, 2010 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 1 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed 2009 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jacqueline Jensen, CFO/Secretary (Sep 10, 2009) |
| Changes vs previous filing |
Compared with the D filed Sep 10, 2009 (EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $12,500. Typical range: $829,831–$9,999,998. Investors: 1. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Filing | Form D filed Sep 10, 2009 SEC file no. 021-134308 · accession 0001471972-09-000001 · filing 1 of 7 in this offering |
|---|---|
| Raise progress | $25,000 sold of $25,000 offered (100%) · $0 remaining · first sale Aug 28, 2009 Issuer's note: Class B Common Stock |
| Filing timing | Date of first sale: Aug 28, 2009 · Form D filed: Sep 10, 2009 (13 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 6,266 days (17.2 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: May 12, 2010 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 1 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
| Minimum investment accepted | $0 as filed (no minimum reported) |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed 2009 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Jacqueline Jensen, CFO/Secretary (Sep 10, 2009) |
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310. Offering size: $25,000. Typical range: $829,831–$9,999,998. Investors: 1. Typical range: 2–15. "Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
| Amendment filed | File no. | Compared with | What changed (both values as filed) |
|---|---|---|---|
| May 12, 2010 EDGAR ↗ | 021-134308 | Apr 1, 2010 D | total sold: $17 (Apr 1, 2010) → $1,750,000 (May 12, 2010) · total offering: $17 (Apr 1, 2010) → $3,000,000 (May 12, 2010) · remaining: $0 (Apr 1, 2010) → $1,250,000 (May 12, 2010) · and 6 more (open the filing above) |
Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Values as filed; no conclusion is drawn.
All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Mar 12, 2014. Industry as reported, by offering: Previous offerings: Other Health Care (2009–2013). Latest offering: Other (Mar 12, 2014).
| Name | Relationship | Address state | On filings (first → last) | Also listed on |
|---|---|---|---|---|
| Alan C. Roga also filed as Alan Roga | Executive Officer, Director, Promoter | AZ | Sep 10, 2009 → Mar 12, 2014 on 11 of 11 filings listed on the latest filing | 1 other issuer |
| Dominic Bagnoli | Director | AZ | Nov 12, 2010 → Mar 12, 2014 on 4 of 11 filings listed on the latest filing | — |
| John Barravecchia | Executive Officer | AZ | Jan 24, 2013 → Mar 12, 2014 on 2 of 11 filings listed on the latest filing | 2 other issuers |
| Michael Osmundson | Director | AZ | Mar 12, 2014 on 1 of 11 filings listed on the latest filing | — |
| Timothy Dickman | Director | AZ | Mar 12, 2014 on 1 of 11 filings listed on the latest filing | — |
| Jeffrey Rein | Director | AZ | Jan 24, 2013 on 1 of 11 filings not listed on the latest filing (Mar 12, 2014) | — |
| Kenneth W. Biel | Director | AZ | Jan 24, 2013 on 1 of 11 filings not listed on the latest filing (Mar 12, 2014) | — |
| Richard D. Gottlieb also filed as Richard Gottlieb | Director | AZ | May 12, 2010 → Jan 24, 2013 on 4 of 11 filings not listed on the latest filing (Mar 12, 2014) | — |
| David Berry | Executive Officer | AZ | Nov 12, 2010 → Aug 19, 2011 on 2 of 11 filings not listed on the latest filing (Mar 12, 2014) | 1 other issuer |
| Glen R. McCracken | Director | AZ | Nov 12, 2010 → Aug 19, 2011 on 2 of 11 filings not listed on the latest filing (Mar 12, 2014) | — |
| Jacqueline Jensen also filed as Jacqueline M. Jensen | Executive Officer, Director, Promoter | AZ | Sep 10, 2009 → Aug 19, 2011 on 8 of 11 filings not listed on the latest filing (Mar 12, 2014) | — |
| John Barton | Executive Officer | AZ | Nov 20, 2009 → Aug 19, 2011 on 6 of 11 filings not listed on the latest filing (Mar 12, 2014) | — |
| James Clough | Director, Promoter | AZ | Sep 10, 2009 → May 12, 2010 on 7 of 11 filings not listed on the latest filing (Mar 12, 2014) | — |
| Jacqueline Jenson | Executive Officer, Director, Promoter | AZ | Sep 23, 2009 on 1 of 11 filings not listed on the latest filing (Mar 12, 2014) | — |
Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings with the same first and last name and no conflicting middle initial are shown on one row (none on this issuer); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗. Middle names: the SEC Form D data set (RELATEDPERSONS.tsv) repeats the previous person's middle name into later rows of the same filing; where that happened PartnerFacts shows the name without the repeated middle name and keeps the data-set spelling on record (Dominic C. Bagnoli; John C. Barravecchia; Michael C. Osmundson; Timothy C. Dickman; Jeffrey W. Rein; David R. Berry; Jacqueline C. Jensen; John R. Barton; John C. Barton) — the filing on EDGAR is the source.
Other issuers listing the same people:
Shared address: this business address appears on no other issuer's filings in our index. As of Oct 23, 2026, 5:45 PM ET.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Not yet searched. Sources to be searched: SEC Investment Adviser Information Reports — Form ADV data for SEC-registered advisers and exempt reporting advisers (file dated 2026-10-02); SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.
Not yet searched.
Sources to be searched: the sponsor's own website (known only from an approved profile claim or the matched adviser's Form ADV) for Meta Pixel ids and Facebook / Instagram page links; Meta Ad Library API: not yet searched (API access pending). We never read facebook.com or instagram.com; readers get a link to Meta's public Ad Library instead.
Not yet collected.
Sources to be searched: sponsor website, Internet Archive, press index (GDELT), Form ADV. A sponsor's website is known only from an approved profile claim or the Form ADV of its matched adviser (Item 1.I); we never look it up elsewhere and never collect personal or family accounts.
Entity standing: not checked (no official programmatic source for AZ yet).
Export this report as PDF (all source links + data timestamp; members · included free during the launch period) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
No corrections have been requested for this page.
Filing-to-filing changes are in Amendment history above.
The complete public-record profile for Stat Health Services Inc., plus the weekly new-filings list.
Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.
Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).
Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.
Free. Get the "Claimed by sponsor" chip and a confirmed contact for corrections. Claiming never changes the public-record section.